Screening and Management of Syphilis in Pregnancy

Initial Screening and Confirmation

• All pregnant individuals should undergo a nontreponemal test (VDRL or RPR) at the first prenatal visit to identify syphilis infection. [@1]
• A positive RPR result must be confirmed with a treponemal assay (e.g., fluorescent treponemal antibody‑absorbed test or TPPA). [@1]

High‑Risk Population Screening

• Pregnant individuals belonging to high‑risk groups (e.g., uninsured, low‑income, sex workers, illicit‑drug users, or residents of communities with high syphilis prevalence) should have repeat serologic testing in the third trimester (≈28 weeks) and again at delivery. [@1][@2]
• Maternal serologic status must be documented before hospital discharge; for high‑risk populations, documentation is required at delivery. [@2]

Treatment Recommendations

• Parenteral benzathine penicillin G is the only recommended therapy for syphilis during pregnancy. [@1]
• Pregnant patients with a penicillin allergy must be desensitized and then treated with penicillin; alternative antibiotics are not considered adequate. [@1]
• Use of non‑penicillin regimens classifies the mother as “untreated” for purposes of infant management. [@3]
• Adequacy of maternal treatment should be assessed by confirming that the sexual partner has also been treated, thereby reducing reinfection risk. [@2]

Post‑Treatment Monitoring

• Follow‑up serologic testing after therapy should employ the same nontreponemal assay (VDRL or RPR) to allow direct comparison of titers. [@1]
• A ≥four‑fold decline in nontreponemal titer indicates an adequate serologic response to treatment. [@3]

Timing Considerations for Delivery

• Treatment administered more than 4 weeks before delivery is considered adequate to prevent congenital syphilis. [@3][@2]
• Treatment given less than 4 weeks before delivery places the infant in the “untreated or inadequately treated mother” category, necessitating full infant evaluation and treatment. [@3]

Documentation and State Mandates

• Most U.S. states require syphilis screening at some point during pregnancy, and many mandate screening at delivery. [@1]
• Neither the mother nor the infant should be discharged unless the maternal serologic status has been documented at least once during the pregnancy. [@2]

Clinical Pitfalls to Avoid

• Do not postpone treatment while awaiting confirmatory treponemal test results in a pregnant person with a positive RPR. [@1]
• Do not use alternative antibiotics without first attempting penicillin desensitization in penicillin‑allergic patients. [@1]
• Failure to document the specific treatment regimen, timing, and serologic response compromises infant management decisions and should be avoided. [@2]
• Umbilical‑cord‑blood screening should be avoided because maternal blood contamination can produce false‑positive results. [@2]

Breastfeeding Recommendations for Mothers with Treated Syphilis (VDRL Positive)

Maternal Treatment Requirements

 The mother must have received intramuscular benzathine penicillin G (the only regimen endorsed by the CDC for syphilis treatment during pregnancy) 1.
 A treatment course completed more than 4 weeks before delivery is regarded as adequate to prevent congenital syphilis, according to CDC guidance 2.

Infant Management When Maternal Treatment Is Adequate

* Infants whose mothers received adequate penicillin therapy (>4 weeks before birth, with appropriate serologic decline and no evidence of reinfection) may be breast‑fed after a single dose of benzathine penicillin G 50,000 U/kg IM or with close serologic monitoring, as recommended by the CDC [1][3].

Infant Management When Maternal Treatment Is Inadequate or Absent

 If the mother is untreated or has received a non‑penicillin regimen, the newborn requires a full work‑up (physical exam, quantitative treponemal serology, cerebrospinal fluid analysis, and long‑bone radiographs) and a 10‑day course of intravenous aqueous crystalline penicillin before breastfeeding can be considered, per CDC recommendations [1][3].
 Symptomatic newborns or those with abnormal evaluation findings must also complete a 10‑day parenteral penicillin regimen prior to initiating lactation, as stipulated by CDC guidelines [1][3].

Interpretation of Serologic Tests in the Infant

* Passive maternal treponemal IgG antibodies may persist in the infant’s circulation for up to 15–18 months without indicating active congenital infection; this is highlighted in CDC guidance 1.